|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | Assistance Publique - Hôpitaux de Paris |
|---|---|
| Information provided by (Responsible Party): | Assistance Publique - Hôpitaux de Paris |
| ClinicalTrials.gov Identifier: | NCT00783887 |
Purpose
Primary ciliary dyskinesia is an inherited respiratory disease caused by various functional and ultrastructural abnormalities of respiratory cilia. The genetic heterogeneity underlying PCD is extremely important and only few genes are clearly implicated in PCD. Their mutations account for about 20% of patients. For all the other PCD patients, the genes responsible for their ciliary defect remain to be identify.
| Condition | Intervention |
|---|---|
|
Primary Ciliary Dyskinesia Kartagener Syndrome |
Other: Blood sample |
| Study Type: | Observational |
| Study Design: | Observational Model: Family-Based Time Perspective: Cross-Sectional |
| Official Title: | Molecular Diagnosis of Primary Ciliary Dyskinesia |
DNA, Serum, White blood cells
| Estimated Enrollment: | 405 |
| Study Start Date: | January 2010 |
| Estimated Study Completion Date: | April 2013 |
| Estimated Primary Completion Date: | January 2013 (Final data collection date for primary outcome measure) |
| Groups/Cohorts | Assigned Interventions |
|---|---|
|
1
Patients with suspected or confirmed primary ciliary dyskinesia after ciliary investigations who accepted to participate to the genetic studies
|
Other: Blood sample
Blood sample of 5 ml
Other Name: Blood sample
|
1/ Evaluating the frequency of mutations of the two main genes implicated in PCD, in a large cohort of patients with PCD confirmed by ciliary investigations.2/ Identifying and testing new candidate genes responsible not only for typical PCD and related disorders of the axoneme, but also for so far-unexplored "syndromic forms of PCD", taking advantage of data obtained through comparative genomic approaches between different species, ciliated or not.
Eligibility| Ages Eligible for Study: | 1 Month and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Patients with suspected or confirmed primary ciliary dyskinesia (followed by the participating centers)
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Serge AMSELEM, MD, PhD | +33 (0) 1 44 73 52 39 | serge.amselem@trs.aphp.fr |
| Contact: Estelle ESCUDIER, MD | +33 (0) 1 44 73 52 39 | estelle.escudier@trs.aphp.fr |
| France | |
| Hôpital A. Trousseau, Service de Génétique et d'Embryologie Médicales | Recruiting |
| Paris, France, 75012 | |
| Contact: Serge AMSELEM, MD, PhD +33 (0) 1 44 73 52 39 serge.amselem@trs.aphp.fr | |
| Principal Investigator: Estelle ESCUDIER, MD | |
| Principal Investigator: | Serge AMSELEM, MD PhD | Assistance Publique - Hôpitaux de Paris |
More Information
| Responsible Party: | Assistance Publique - Hôpitaux de Paris |
| ClinicalTrials.gov Identifier: | NCT00783887 History of Changes |
| Other Study ID Numbers: | AOM 06053 |
| Study First Received: | October 31, 2008 |
| Last Updated: | December 26, 2011 |
| Health Authority: | France: Ministry of Health |
|
Cilia Axoneme Dynein |
Gene Ultrastructure Linkage analysis |
|
Ciliary Motility Disorders Kartagener Syndrome Dyskinesias Respiratory Tract Diseases Otorhinolaryngologic Diseases Bronchiectasis Bronchial Diseases Respiratory System Abnormalities Dextrocardia Heart Defects, Congenital Cardiovascular Abnormalities |
Cardiovascular Diseases Heart Diseases Congenital Abnormalities Situs Inversus Genetic Diseases, Inborn Movement Disorders Central Nervous System Diseases Nervous System Diseases Neurologic Manifestations Signs and Symptoms |